The FDA has determined that human pregnancy data for Ebglyss® remain insufficient. By enrolling U.S. and Canadian participants, this study will help generate the evidence needed to inform future treatment decisions. PRESS RELEASE San Diego, CA — Pregnant women with moderate-to-severe eczema and their healthcare providers face a difficult evidence gap: how to make treatment decisions when human pregnancy data for newer therapies remain limited.MotherToBaby has launched a new observational …
Press Releases: MotherToBaby News
MotherToBaby Launches New Educational Webinars and Infographics for Healthcare Providers During National Birth Defects Awareness Month
PRESS RELEASE Brentwood, TN — MotherToBaby, a service of the Organization of Teratology Information Specialists (OTIS), today announced the launch of two brand new resource hubs—a dedicated webinar repository and a collection of downloadable infographics—to equip healthcare providers with evidence-based tools for patient education and clinical practice. The announcement coincides with National Birth Defects Awareness Month (NBDAM), observed every January. Each year, approximately 1 in 33 …
